{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Brain+Scan&page=31", "query": { "intervention": "Brain Scan", "page": 31 }, "page_size": 10 }, "pagination": { "page": 31, "page_size": 10, "total_count": 775, "total_pages": 78, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Brain+Scan&page=32&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Brain+Scan&page=30&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T08:16:40.204Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04047602", "title": "Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Tumor", "Brain Metastases", "Brain Cancer" ], "interventions": [ { "name": "Reduced Dose SRS", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2019-12-12", "completion_date": "2024-02-20", "has_results": true, "last_update_posted_date": "2025-02-13", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 3, "location_summary": "Indianapolis, Indiana • Portland, Oregon", "locations": [ { "city": "Indianapolis", "state": "Indiana" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04047602" }, { "nct_id": "NCT05288439", "title": "A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Tumor", "Metastatic Brain Tumor" ], "interventions": [ { "name": "Resting-state functional connectivity MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Neurocognitive battery with quality-of-life assessment", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "6 Years to 25 Years" }, "enrollment_count": 30, "start_date": "2022-03-07", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05288439" }, { "nct_id": "NCT07568145", "title": "The PREVENT Resilience Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psychological Trauma" ], "interventions": [ { "name": "Transcranial Magnetic Stimulation (TMS)", "type": "DEVICE" }, { "name": "TMS Sham", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2026-06-18", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07568145" }, { "nct_id": "NCT06580002", "title": "Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Sarcoma", "Gastric Cancer", "Lung Cancer", "Head and Neck Cancer", "Colorectal Cancer", "Ovarian Cancer", "Liver Cancer", "Genitourinary Cancer", "Gynecologic Cancer", "Urinary Bladder Cancer", "Leukemia", "Lymphoid Leukemia", "Myeloma Multiple", "Prostate Cancer", "Pancreas Cancer", "Non-hodgkin Lymphoma", "Hodgkin Lymphoma", "Brain Cancer", "Melanoma", "Mycosis Fungoides", "Kidney Cancer" ], "interventions": [ { "name": "Riluzole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2024-12-02", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06580002" }, { "nct_id": "NCT07510607", "title": "Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis", "RRMS", "Relapsing Remitting MS" ], "interventions": [ { "name": "HP 13C pyruvate injection", "type": "DRUG" }, { "name": "MRI Scanner", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Ari Green", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2026-06-03", "completion_date": "2029-12-01", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07510607" }, { "nct_id": "NCT04733638", "title": "ADVANCE- Automated Detection and Volumetric Assessment of ICH", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Intracerebral Hemorrhage" ], "interventions": [ { "name": "Viz ICH VOLUME", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Viz.ai, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2021-01-26", "completion_date": "2023-04-28", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 5, "location_summary": "Englewood, Colorado • New York, New York • Charlotte, North Carolina + 2 more", "locations": [ { "city": "Englewood", "state": "Colorado" }, { "city": "New York", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Greenville", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04733638" }, { "nct_id": "NCT06058663", "title": "Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Locally Advanced Intrahepatic Cholangiocarcinoma", "Oligometastatic Intrahepatic Cholangiocarcinoma", "Stage III Intrahepatic Cholangiocarcinoma AJCC v8", "Stage IV Intrahepatic Cholangiocarcinoma AJCC v8", "Unresectable Intrahepatic Cholangiocarcinoma" ], "interventions": [ { "name": "Angiography", "type": "PROCEDURE" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Durvalumab", "type": "BIOLOGICAL" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Tremelimumab", "type": "BIOLOGICAL" }, { "name": "Yttrium-90 Microsphere Radioembolization", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2024-06-06", "completion_date": "2028-11-30", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06058663" }, { "nct_id": "NCT00857506", "title": "Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease", "Mild Cognitive Impairment" ], "interventions": [ { "name": "florbetapir F 18", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avid Radiopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 152, "start_date": "2009-01", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2013-03-28", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 8, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Costa Mesa, California + 5 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Brooksville", "state": "Florida" }, { "city": "Hallandale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857506" }, { "nct_id": "NCT04373720", "title": "MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Glioma" ], "interventions": [ { "name": "Magnetic Resonance Elastography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2020-03-20", "completion_date": "2028-11-01", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04373720" }, { "nct_id": "NCT03071224", "title": "Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alzheimer Disease", "Healthy Volunteers" ], "interventions": [ { "name": "[18F] MNI-946", "type": "DRUG" }, { "name": "[18F]Florbetapir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Invicro", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 10, "start_date": "2016-06", "completion_date": "2021-06-09", "has_results": false, "last_update_posted_date": "2021-06-14", "last_synced_at": "2026-10-28T08:16:40.204Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03071224" } ] }